S
Scotiabank Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
251
Tempest Therapeutics
TPST
$48.2M
|
GF
George Farmer
| $11 | $9 |
18%
downside
| Sector Perform |
10 Apr ‘25
5 months ago |
|
252
Brookfield
BN
$99B
|
MS
Mario Saric
| $66.19 | $68 |
3%
upside
| Sector Outperform |
7 Apr ‘25
5 months ago |
|
253
Terreno Realty
TRNO
$6.07B
|
GM
Greg McGinniss
| $57.70 | $57 |
1%
downside
| Sector Perform |
7 Apr ‘25
5 months ago |
|
254
Edgewise Therapeutics
EWTX
$1.57B
|
LC
Louise Chen
| $14.75 | $14 |
5%
downside
| Sector Perform |
3 Apr ‘25
5 months ago |
|
255
Bionano Genomics
BNGO
$20.5M
|
SJN
Sung Ji Nam
| $4.38 | $4 |
9%
downside
| Sector Perform |
2 Apr ‘25
5 months ago |
|
|
LAC
256
Lithium Americas
LAC
$686M
|
BI
Ben Isaacson
| $2.84 | $2.75 |
3%
downside
| Sector Perform |
31 Mar ‘25
5 months ago |
|
257
Descartes Systems
DSGX
$9.19B
|
KK
Kevin Krishnaratne
| $106.95 | $127 |
19%
upside
| Sector Outperform |
26 Mar ‘25
5 months ago |
|
258
Quanterix
QTRX
$199M
|
SN
Sung Nam
| $4.29 | $18 |
320%
upside
| Sector Outperform |
25 Mar ‘25
5 months ago |
|
259
Pacific Biosciences
PACB
$393M
|
SJN
Sung Ji Nam
| $1.31 | $2 |
53%
upside
| Sector Outperform |
25 Mar ‘25
5 months ago |
|
|
ADAP
260
Adaptimmune Therapeutics
ADAP
$13M
|
GF
George Farmer
| $0.0492 | $1.40 |
2,746%
upside
| Sector Outperform |
21 Mar ‘25
5 months ago |
|
261
Workday
WDAY
$61.9B
|
AV
Allan Verkhovski
| $230.73 | $305 |
32%
upside
| Sector Outperform |
17 Mar ‘25
5 months ago |
|
262
Dayforce
DAY
$10.9B
|
AV
Allan Verkhovski
| $68.90 | $55 |
20%
downside
| Sector Perform |
17 Mar ‘25
5 months ago |
|
263
Salesforce
CRM
$240B
|
AV
Allan Verkhovski
| $252.06 | $345 |
37%
upside
| Sector Outperform |
17 Mar ‘25
5 months ago |
|
264
Autodesk
ADSK
$69.3B
|
AV
Allan Verkhovski
| $325.19 | $315 |
3%
downside
| Sector Outperform |
17 Mar ‘25
5 months ago |
|
265
Sprinklr
CXM
$1.93B
|
AV
Allan Verkhovski
| $7.85 | $9 |
15%
upside
| Sector Perform |
13 Mar ‘25
6 months ago |
|
266
Upwork
UPWK
$2.12B
|
NS
Nat Schindler
| $16 | $15 |
6%
downside
| Sector Perform |
12 Mar ‘25
6 months ago |
|
267
Beam Therapeutics
BEAM
$2.06B
|
GH
Greg Harrison
| $20.36 | $40 |
96%
upside
| Sector Outperform |
10 Mar ‘25
6 months ago |
|
268
Southern Copper
SCCO
$84B
|
AS
Alfonso Salazar
| $99.91 | $71.29 |
29%
downside
| Sector Underperform |
10 Mar ‘25
6 months ago |
|
269
Gain Therapeutics
GANX
$61.5M
|
LC
Louise Chen
| $1.71 | $12 |
602%
upside
| Sector Outperform |
7 Mar ‘25
6 months ago |
|
270
Innoviva
INVA
$1.29B
|
LC
Louise Chen
| $20.18 | $55 |
173%
upside
| Sector Outperform |
7 Mar ‘25
6 months ago |
|
271
PTC Therapeutics
PTCT
$4.52B
|
LC
Louise Chen
| $58.42 | $55 |
6%
downside
| Sector Perform |
7 Mar ‘25
6 months ago |
|
272
Perspective Therapeutics
CATX
$255M
|
LC
Louise Chen
| $3.37 | $15 |
345%
upside
| Sector Outperform |
7 Mar ‘25
6 months ago |
|
|
PVLA
273
Palvella Therapeutics, Inc. Common Stock
PVLA
$609M
|
LC
Louise Chen
| $56.71 | $50 |
12%
downside
| Sector Outperform |
7 Mar ‘25
6 months ago |
|
274
Ardelyx
ARDX
$1.58B
|
LC
Louise Chen
| $6.56 | $15 |
129%
upside
| Sector Outperform |
7 Mar ‘25
6 months ago |
|
275
Cogent Biosciences
COGT
$1.77B
|
LC
Louise Chen
| $12.82 | $17 |
33%
upside
| Sector Outperform |
7 Mar ‘25
6 months ago |
|